Analysis of sialic acid levels in Chinese intravenous immunoglobulins by high-performance liquid chromatography with fluorescence detection.

Intravenous immunoglobulin (IVIg) is increasingly used for the treatment of autoimmune and systemic inflammatory diseases with both licensed and off-label indications. Recent studies indicated that IVIg-mediated immunomodulation and anti-inflammation are closely associated with the IgG sialylation, especially with IgG crystallizable fragment (Fc) sialylation. The sialic acid levels of the IgG molecules and Fc fragments in 12 IVIg preparations from six Chinese manufacturers were evaluated. The Fc fragments were derived from the papain digestion of IVIg, followed by affinity and size exclusion chromatography. The sialic acid levels in Fc fragments and IVIg preparations were determined by high-performance liquid chromatography with fluorescence detection, after the sialic acid residues were released from the proteins. The results showed that the sialic acid levels in Chinese IVIg preparations ranged from 0.875 (mol/mol IgG) to 1.085 (mol/mol IgG), and the sialic acid levels in Fc fragments were from 0.321 (mol/mol Fc) to 0.361 (mol/mol Fc). Furthermore, the sialic acid levels of IVIg preparations and Fc fragments from different Chinese manufactures were significantly different. These findings will contribute to an increased understanding of Chinese IVIg preparations and the relationship between the sialic acid levels in IVIg preparations and their clinical efficacy in future clinical studies.

[1]  Fengjuan Liu,et al.  In vitro evaluation of the biological activities of IgG in seven Chinese intravenous immunoglobulin preparations , 2018, Journal of pharmaceutical and biomedical analysis.

[2]  R. M. Anthony,et al.  Engineered Sialylation of Pathogenic Antibodies In Vivo Attenuates Autoimmune Disease , 2017, Cell.

[3]  Fengjuan Liu,et al.  Demonstration of the IgG antibody repertoire against the bacteria Escherichia coli in Chinese intravenous immunoglobulins , 2017, Journal of pharmaceutical and biomedical analysis.

[4]  A. Manning,et al.  Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity , 2015, Proceedings of the National Academy of Sciences.

[5]  F. Nimmerjahn,et al.  Role of sialylation in the anti‐inflammatory activity of intravenous immunoglobulin – F(ab′)2 versus Fc sialylation , 2014, Clinical and experimental immunology.

[6]  L. Mouthon,et al.  In vitro and in vivo properties differ among liquid intravenous immunoglobulin preparations , 2013, Vox sanguinis.

[7]  A. Zuercher,et al.  Analysis and Functional Consequences of Increased Fab-Sialylation of Intravenous Immunoglobulin (IVIG) after Lectin Fractionation , 2012, PloS one.

[8]  G. Schett,et al.  IVIg‐mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1 , 2012, European journal of immunology.

[9]  A. Lux,et al.  The role of sialic acid as a modulator of the anti-inflammatory activity of IgG , 2012, Seminars in Immunopathology.

[10]  L. French,et al.  Not all intravenous immunoglobulin preparations are equally well tolerated. , 2010, Acta dermato-venereologica.

[11]  J. Ravetch,et al.  A Novel Role for the IgG Fc Glycan: The Anti-inflammatory Activity of Sialylated IgG Fcs , 2010, Journal of Clinical Immunology.

[12]  A. Alegría,et al.  Determination of sialic acid and gangliosides in biological samples and dairy products: a review. , 2010, Journal of pharmaceutical and biomedical analysis.

[13]  R. Rueda,et al.  Application of a sensitive fluorometric HPLC assay to determine the sialic acid content of infant formulas , 2007, Analytical and bioanalytical chemistry.

[14]  J. Ravetch,et al.  Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation , 2006, Science.

[15]  E. Gelfand.  Differences between IGIV products: impact on clinical outcome. , 2006, International immunopharmacology.

[16]  P. Korenblat,et al.  Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency. A randomized double-blind trial. , 2003, International immunopharmacology.

[17]  Y. Ohkura,et al.  Fluorometric high-performance liquid chromatography of N-acetyl- and N-glycolylneuraminic acids and its application to their microdetermination in human and animal sera, glycoproteins, and glycolipids. , 1987, Analytical biochemistry.

[18]  J. Cabezas,et al.  SIALIC ACID (N-ACETYLNEURAMINIC ACID) IN HUMAN SERUM. , 1964, Clinical chemistry.

[19]  Sundaravalli Pa.  Composition analysis of intravenous immunoglobulin from seven Chinese blood fractionation industries , 2014 .

[20]  A. L. Jensen,et al.  Evaluation of an automated spectrophotometric assay for the determination of total sialic acid in canine serum , 2005, Veterinary Research Communications.

[21]  S. Avrameas,et al.  Effects of pH or ionic strength on the reactivities of mono- and polyspecific IgG antibodies. , 1994, Research in immunology.

[22]  G. Dimitrov.  A spectrophotometric method for qualitative and quantitative determination of sialic acid in glycoproteins and glycopeptides. , 1973, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.